Pamela Dean, PhD
Neuropsychology
Highlights
Languages
- American Sign Language
- English
Gender
FemaleAbout Pamela Dean
Biography
Pamela M. Dean, Ph.D., ABPP, is a board-certified Clinical Neuropsychologist through the American Board of Professional Psychology. She is appointed in the Center for General Neurology with special interests in the evaluation and behavioral management of neurodegenerative disorders and brain tumors. She also is proficient in American Sign Language and has an interest in providing neuropsychological evaluations to prelingually Deaf and Hard of Hearing patients. Her research interests include both neurologic and rehabilitation populations, respectively. Dr. Dean serves on several national neuropsychology professional organizations and holds leadership roles that focus on education, training, mentorship, and professional advocacy. She also is the Director of the Clinical Neuropsychology Post-Doctoral Fellowship Program at the Cleveland Clinic (Ohio).
Education & Board Certifications
Education
- Fellowship: Mayo Clinic College of Medicine, 2012
- Graduate School: Gallaudet University, 2010
- Internship: James A. Haley Veterans Hospital, 2010
- Undergraduate: San Diego State University (California), 2004
Board Certifications
- Clinical Neuropsychology: American Board of Professional Psychology, 2014
Research & Publications
See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.
As of 2026-01-06, Dr. Dean has reported no financial relationship with industry that is applicable to this listing.
In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.